Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: BOD - At this point, I suspect it's hard to find a CEO willing to work with you

"coupled with divestiture of PDSG (hopefully for a profit or at least break-even after tax benefits)"

We paid $10 million for it, it's been valued at $1.8 million by an outside consultant, and you think/hope we might sell it at a profit?

I can't even comment on that line of thinking.

Share
New Message
Please login to post a reply